Apr 01 2014 10:17 AMNews & Views

Summit Partners Makes a Minority Investment in IDT

 

Integrated DNA Technologies (IDT) has announced a minority investment by growth equity investor Summit Partners. IDT’s founder, Dr. Joseph Walder, will remain the company’s majority owner. Additional terms of the investment were not disclosed.

One of the largest manufacturers of custom nucleic acid products the company supplies scientists with synthetic DNA and RNA sequences, serving the academic research, biotechnology, clinical diagnostics, and pharmaceutical sectors. “Our success is based on the highest quality custom biology products, delivered quickly, and a significant investment in research and development,” said Dr. Walder. “My team and I have gotten to know Summit over several years and we are confident they will add significant value to our organisation. We look forward to partnering with Summit to grow our business.”

“We are very enthusiastic about working with Dr. Walder and the team at IDT,” said Michael Anderson, a Principal at Summit Partners who joined IDT’s Board of Directors. “IDT is the clear market-leader in the field of synthetic DNA, serving a very large and diversified customer base. The strong and long-term relationships that the company has built with its customers are extremely impressive.”

Craig Frances, MD, a Managing Director with Summit Partners who also joined IDT’s Board, added, “IDT has the highest quality products and best customer service in the world, which is why more than 82,000 researchers rely on the company. Dr. Walder and his team are truly pioneers in the life science tools sector and we are very pleased to be their partner.”

Request more information

You are requesting more details on: Summit Partners Makes a Minority Investment in IDT .

Your details will be referred to Integrated DNA Technologies and they will provide you with more information regarding this press release themselves. If you have not logged into the website, then please enter your details below.

Contact Details:

* Required fields

top of page Filed under: News & Views

Reader Comments (Total 0 comments)

Post a comment

Do you like or dislike what you have read? Why not post a comment to tell others / the manufacturer and our Editor what you think. To leave comments please complete the form below. Providing the content is approved, your comment will be on screen in less than 24 hours. Leaving comments on product information and articles can assist with future editorial and article content. Post questions, thoughts or simply whether you like the content.

Post your comment:

top of page